In a clinical-adjacent product, the mature stance is: assume the model will be wrong sometimes and engineer for it — strict grounding abstain-on-low-coverage visible citations and evidence never altering a recorded variant classification a persistent "informational, not diagnostic; consult your clinician" boundary full audit logging Talk about red-teaming for hallucinated significance and prompt injection. This shows you take the domain's stakes seriously, which is exactly what a genomics employer needs to trust you.